These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19680047)

  • 1. A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy.
    Caprioli J; Zeyen T
    J Glaucoma; 2009 Aug; 18(6 Suppl):S1-21. PubMed ID: 19680047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in optical coherence tomography for glaucoma.
    Chang R; Budenz DL
    Curr Opin Ophthalmol; 2008 Mar; 19(2):127-35. PubMed ID: 18301286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of retinal nerve fiber layer thickness in normal eyes, ocular hypertensives, preperimetric glaucoma and glaucomatous subjects.
    Polo V; Larrosa JM; Ferreras A; de la Casa JM; Pablo LE; Honrubia FM
    Ann Ophthalmol (Skokie); 2009; 41(1):24-30. PubMed ID: 19413224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Long-term measurement variability with scanning laser polarimetry employing enhanced corneal compensation: an early sign of glaucoma progression.
    Tóth M; Holló G
    J Glaucoma; 2008; 17(7):571-7. PubMed ID: 18854736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing glaucoma progression: current practice and promising technologies.
    Giangiacomo A; Garway-Heath D; Caprioli J
    Curr Opin Ophthalmol; 2006 Apr; 17(2):153-62. PubMed ID: 16552250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anatomy, physiology, and functional exploration of the optic nerve].
    Ingster-Moati I; Rigaudière F
    Rev Prat; 2001 Dec; 51(20):2185-92. PubMed ID: 11828631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of glaucoma imaging technology.
    Azuara-Blanco A; Burr JM
    Ophthalmology; 2008 Jul; 115(7):1266-7; author reply 1267-8. PubMed ID: 18598824
    [No Abstract]   [Full Text] [Related]  

  • 9. [Optic neuropathy in children and adolescents with postuveal glaucoma].
    Katargina LA; Gvozdiuk NA; Meshkova GI; Shamshinova AM
    Vestn Oftalmol; 2008; 124(6):44-6. PubMed ID: 19205403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven steps to assure the best possible treatment of persons with glaucoma or suspected of having glaucoma.
    Spaeth GL
    Oftalmologia; 1999; 49(4):19-34. PubMed ID: 11021281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in glaucoma.
    Resch H; Garhofer G; Fuchsjäger-Mayrl G; Hommer A; Schmetterer L
    Acta Ophthalmol; 2009 Feb; 87(1):4-12. PubMed ID: 18507728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unpredictability of glaucoma progression.
    Susanna R
    Curr Med Res Opin; 2009 Sep; 25(9):2167-77. PubMed ID: 19601708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tendencies in the etiopathogenesis of glaucoma--present and future].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(3):10-22. PubMed ID: 19149112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What changes can we expect in the brain of glaucoma patients?
    Gupta N; Yücel YH
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S122-6. PubMed ID: 17998036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems for staging the amount of optic nerve damage in glaucoma: a critical review and new material.
    Spaeth GL; Lopes JF; Junk AK; Grigorian AP; Henderer J
    Surv Ophthalmol; 2006; 51(4):293-315. PubMed ID: 16818081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma screening: current trends, economic issues, technology, and challenges.
    Nduaguba C; Lee RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):142-52. PubMed ID: 16552249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual function measures in experimental glaucoma.
    Johnson CA
    J Glaucoma; 1997 Dec; 6(6):351-2. PubMed ID: 9407360
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of retinal nerve fiber layer thickness values using Stratus Optical Coherence Tomography and Heidelberg Retina Tomograph-III.
    Moreno-Montañés J; Antón A; García N; Olmo N; Morilla A; Fallon M
    J Glaucoma; 2009 Sep; 18(7):528-34. PubMed ID: 19745667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.